IRadimed (IRMD) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRadimed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IRMD shares.
View IRMD analyst ratings or view top-rated stocks.

1 brokers have issued 12 month target prices for IRadimed's shares. Their IRMD share price forecasts range from $48.00 to $60.00. On average, they anticipate the company's stock price to reach $54.00 in the next year. This suggests a possible upside of 24.8% from the stock's current price.
View analysts price targets for IRMD or view top-rated stocks among Wall Street analysts.

IRadimed's stock was trading at $28.29 at the beginning of the year. Since then, IRMD shares have increased by 53.0% and is now trading at $43.28.
View the best growth stocks for 2023 here.

IRadimed saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 76,000 shares, a decline of 7.2% from the August 15th total of 81,900 shares. Based on an average daily trading volume, of 36,800 shares, the short-interest ratio is currently 2.1 days. Currently, 1.0% of the shares of the stock are sold short.
View IRadimed's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our IRMD earnings forecast.

IRadimed Co. (NASDAQ:IRMD) issued its quarterly earnings results on Thursday, August, 3rd. The medical equipment provider reported $0.33 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.05. The medical equipment provider had revenue of $16.13 million for the quarter, compared to analysts' expectations of $15.70 million. IRadimed had a net margin of 24.53% and a trailing twelve-month return on equity of 21.22%.

IRadimed announced a dividend on Monday, February 6th. Stockholders of record on Monday, February 13th will be given a dividend of $1.05 per share on Tuesday, February 21st. This represents a dividend yield of 2.54%. The ex-dividend date of this dividend is Friday, February 10th. This is a positive change from the stock's previous dividend of $1.00.
Read our dividend analysis for IRMD.

Ballast Small/Mid Cap ETF holds 19,404 shares of IRMD stock, representing 0.98% of its portfolio.

IRadimed issued an update on its third quarter 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of $0.36-$0.38 for the period, compared to the consensus EPS estimate of $0.33. The company issued revenue guidance of $16.10 million-$16.30 million, compared to the consensus revenue estimate of $15.60 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other IRadimed investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Alphabet (GOOG), Mastercard (MA), Micron Technology (MU), PayPal (PYPL), CRISPR Therapeutics (CRSP), IntriCon (IIN), QUALCOMM (QCOM) and Twitter (TWTR).

IRadimed trades on the NASDAQ under the ticker symbol "IRMD."

IRadimed's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (4.62%), BlackRock Inc. (3.94%), RK Capital Management LLC (2.29%), Bares Capital Management Inc. (2.20%), Ranger Investment Management L.P. (1.78%) and Russell Investments Group Ltd. (1.73%). Insiders that own company stock include Anthony Vuoto, Christopher K Scott, James B Hawkins, Monty K Allen, Monty K Allen and Roger E Susi.
View institutional ownership trends.

Shares of IRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IRMD stock can currently be purchased for approximately $43.28.

IRadimed (NASDAQ:IRMD) has a market capitalization of $545.33 million and generates $53.30 million in revenue each year. The medical equipment provider earns $12.83 million in net income (profit) each year or $1.16 on an earnings per share basis.

The company employs 123 workers across the globe.

IRadimed's mailing address is 1025 Willa Springs Dr., Winter Springs FL, 32708. The official website for the company is www.iradimed.com. The medical equipment provider can be reached via phone at (407) 677-8022, via email at investorrelations@iradimed.com, or via fax at 407-677-5037.